Literature DB >> 12182627

Gamma-hydroxy-alpha,beta-alkenenitriles: chelation-controlled conjugate additions.

Fraser F Fleming1, Qunzhao Wang, Zhiyu Zhang, Omar W Steward.   

Abstract

Temporarily anchoring Grignard and organolithium reagents to gamma-hydroxy-alpha,beta-alkenenitriles promotes efficient conjugate additions to what are otherwise recalcitrant Michael acceptors. Sequential deprotonation and addition of a modest excess of a second Grignard reagent allows effective conjugate delivery of alkyl groups to cyclic and acyclic alkenenitriles. Mechanistically, conjugate additions proceed through alkylmagnesium alkoxide complexes for all but the more substituted alkenenitriles that require alkyl transfers from the more reactive ate complexes. Synthetically, chelation-controlled conjugate additions rapidly, and stereoselectively, assemble substituted nitriles, installing up to two new stereocenters in a single synthetic operation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12182627     DOI: 10.1021/jo0258150

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

1.  Cyclic oxonitriles: stereodivergent grignard addition-alkylations.

Authors:  Fraser F Fleming; Guoqing Wei; Zhiyu Zhang; Omar W Steward
Journal:  J Org Chem       Date:  2007-06-13       Impact factor: 4.354

2.  Metalated Nitriles: Stereodivergent Cation-Controlled Cyclizations1.

Authors:  Fraser F Fleming; Yunjing Wei; Wang Liu; Zhiyu Zhang
Journal:  Tetrahedron       Date:  2008-08-04       Impact factor: 2.457

3.  C-metalated nitriles: electrophile-dependent alkylations and acylations.

Authors:  Fraser F Fleming; Zhiyu Zhang; Guoqing Wei; Omar W Steward
Journal:  J Org Chem       Date:  2006-02-17       Impact factor: 4.354

4.  Continuous Flow Sodiation of Substituted Acrylonitriles, Alkenyl Sulfides and Acrylates.

Authors:  Johannes H Harenberg; Niels Weidmann; Konstantin Karaghiosoff; Paul Knochel
Journal:  Angew Chem Int Ed Engl       Date:  2020-11-03       Impact factor: 16.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.